Âé¶¹ÒùÔº


Bioelectrosynthesis platform enables switch-like, precision control of cell signaling

KAIST Develops Bioelectrosynthesis Platform for Switch-Like Precision Control of Cell Signaling​
Credit: Angewandte Chemie (2025). DOI: 10.1002/ange.202508192

Cells use various signaling molecules to regulate the nervous, immune, and vascular systems. Among these, nitric oxide (NO) and ammonia (NH₃) play important roles, but their chemical instability and gaseous nature make them difficult to generate or control externally.

A KAIST research team has developed a platform that generates specific signaling molecules in situ from a single precursor under an applied electrical signal, enabling switch-like, precise spatiotemporal control of cellular responses. This approach could provide a foundation for future medical technologies such as electroceuticals, electrogenetics, and personalized cell therapies.

The research team led by Professor Jimin Park from the Department of Chemical and Biomolecular Engineering, in collaboration with Professor Jihan Kim's group, has developed a bioelectrosynthesis platform capable of producing either or on demand using only an electrical signal. The platform allows control over the timing, spatial range, and duration of cell responses.

The findings are in Angewandte Chemie.

Inspired by enzymes involved in nitrite reduction, the researchers implemented an electrochemical strategy that selectively produces nitric oxide or ammonia from a single precursor, nitrite (NO2â»). By changing the catalyst, the team generated ammonia or nitric oxide from nitrite using a copper-molybdenum-sulfur catalyst (Cu2MoS4) and an iron-incorporated catalyst (FeCuMS4), respectively.

Through and , the team revealed that Fe sites in the FeCuMoS4 catalyst bind nitric oxide intermediates more strongly, shifting product selectivity toward nitric oxide. Under the same electrical conditions, the Fe-containing catalyst preferentially produces nitric oxide, whereas the Cu2MoS4 catalyst favors ammonia production.

KAIST Develops Bioelectrosynthesis Platform for Switch-Like Precision Control of Cell Signaling​
Credit: Angewandte Chemie (2025). DOI: 10.1002/ange.202508192

The research team demonstrated biological functionality by using the platform to activate in human cells. Specifically, electrochemically produced nitric oxide activated TRPV1 channels (responsive to heat and chemical stimuli), while electrochemically produced ammonia induced intracellular alkalinization and activated OTOP1 proton channels. By tuning the and electrolysis duration, the team modulated the onset time, spatial extent, and termination of cellular responses, which effectively turned cellular signaling on and off like a switch.

Professor Park said, "This work is significant because it enables precise cellular control by selectively producing signaling molecules with electricity. We believe it has strong potential for applications in electroceutical technologies targeting the nervous system or metabolic disorders."

More information: Myeongeun Lee et al, Bioelectrosynthesis of Signaling Molecules for Selective Modulation of Cell Signaling, Angewandte Chemie (2025).

Journal information: Angewandte Chemie

Citation: Bioelectrosynthesis platform enables switch-like, precision control of cell signaling (2025, August 13) retrieved 13 August 2025 from /news/2025-08-bioelectrosynthesis-platform-enables-precision-cell.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New copper/cobalt catalyst improves efficiency of electrochemical nitrate reduction

0 shares

Feedback to editors